Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
Allergy & Immunology
•
Immunosuppression
•
Anaphylaxis
•
Allergy
•
Immunology
Are there any immunosuppressive agents that have been shown to have utility in concurrent idiopathic anaphylaxis?
Patient with seropositive RA, immunodeficiency, and idiopathic anaphylaxis.
Related Questions
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
Is it safe to use one TNF inhibitor (e.g., infliximab) in a patient who has had a severe allergic reaction to a different TNF inhibitor (e.g., adalimumab)?
How do you approach management of recurrent idiopathic pleuropericarditis?
What additional workup would you perform to evaluate a new onset of spontaneous hemarthrosis?
When do you prefer bariatric surgery such as sleeve gastrectomy or gastric bypass over an initial trial of a GLP-1 receptor agonist in patients with severe obesity and painful knee or hip osteoarthritis?
How do you approach the use of immunosuppressive therapy in patients with rheumatoid arthritis and underlying immunodeficiency, such as IgA deficiency?
Do you continue PJP prophylaxis indefinitely in patients on rituximab maintenance therapy?